Leatt Corp (LEAT) Stock Price & Analysis

Leatt Corp (LEAT) fell 0.41% to USD 12.2 as of September 8, 2026 at 16:05 UTC, according to Nexqual real-time market data.

LEAT last closed at USD 12.2; the session ranged USD 12.2–12.2 on volume of 100 shares. Market capitalization is —, with a 52-week range of USD 8.31–13.37 (OQB). Source: Nexqual, September 8, 2026 at 16:05 UTC.

Key Statistics (as of September 8, 2026 at 16:05 UTC)

Technical Analysis (LEAT)

Nexqual's technical model rates LEAT "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 16:05 UTC.

From Leatt Corp's Latest SEC 10-K Filing (filed 2026-03-24)

Key Strengths & Strategy (as disclosed to the SEC)

• FDA and MHRA registration allow us to take these products directly to market as medical devices for patients (not just athletes) recuperating from injuries, surgery, muscle tears or strains, dislocations, breaks or fractures.
• Both our patents and licensed patented technology allows us to provide a product that cannot easily be duplicated by our competitors.
• While such manufacturing arrangements pose a risk to our ability to safeguard our proprietary technologies and may lead to increased costs, as discussed under the "Risk Factors" heading in this report, we expect that the increase in expected sales volumes will contribute to a lower production cost per unit and that this will translate to better margins for our distributors and retailers. •   Research, Development, Certification and Marketing Capabilities .

Partnerships

• De Villiers shares of preferred stock, we entered into a Settlement Agreement with them, pursuant to which they agreed to release us from any and all liability arising out of or related to our failure to satisfy our prior obligation to them, and we issued 16,800,000 shares of our common stock and 2,400,000 shares of our Series A Preferred Stock to Dr.
• Jarrett in accordance with the agreement, but we did not issue any preferred shares to Dr.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 16:05 UTC. This page is informational and not investment advice.